Ko-ichi Ohtaki
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Analysis of Onset Timing and Risk Factors for Mesalazine-related Adverse Events Using the JADER Database.
Journal: In vivo (Athens, Greece)
Published: October 06, 2025
Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.
Journal: Anticancer research
Published: September 23, 2025
Correlation of lymphocyte-to-monocyte, platelet-to-lymphocyte, and neutrophil-to-lymphocyte ratios with skin-symptom improvement following antimicrobial treatment in palmoplantar pustulosis.
Journal: Journal of pharmaceutical health care and sciences
Published: June 05, 2025
Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH.
Journal: International journal of radiation biology
Published: July 11, 2024
Survey of Pharmacist-Led Medication Guidance for Patients with Inflammatory Bowel Disease in Japan.
Journal: Inflammatory intestinal diseases
Published: April 25, 2024
Low concentrations of clarithromycin upregulate cellular antioxidant enzymes and phosphorylation of extracellular signal-regulated kinase in human small airway epithelial cells.
Journal: Journal of pharmaceutical health care and sciences
Published: January 30, 2018
Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression.
Journal: BMC pharmacology & toxicology
Published: July 02, 2016
Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
Journal: Neuroscience letters
Published: March 23, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026